Lower Saxony Center for Nephrology Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2000
NCT00373165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Alternative names

Lower Saxony Center for Nephrology, Transplantation Center, Department of Nephrology

Active Ingredients

Drugs in Phase 4 Trials (1)

ganciclovir (cytovene) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Cytomegalovirus Infections (Phase 4)

DNA Virus Infections (Phase 4)

Herpesviridae Infections (Phase 4)

Infections (Phase 4)

Virus Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1